GERM
Amplify Treatments, Testing and Advancements ETF
GERM
GERM
Delisted
GERM was delisted on the 5th of September, 2024.
11 hedge funds and large institutions have $1.43M invested in Amplify Treatments, Testing and Advancements ETF in 2024 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
11
Holders Change
–
Holders Change %
0%
% of All Funds
0.16%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
2
Reduced
4
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
Citadel Advisors
Miami,
Florida
|
+$221K |
2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$98K |
3 |
PCMC
Planning Capital Management Corporation
Paoli,
Pennsylvania
|
+$19 |
Top Sellers
1 |
UBS Group
Zurich,
Switzerland
|
-$9.12K |
2 |
IA
IFP Advisors
Tampa,
Florida
|
-$3.64K |
3 |
CHC
City Holding Co
Charleston,
West Virginia
|
-$3K |
4 |
Osaic Holdings
Scottsdale,
Arizona
|
-$2.11K |